Study Title

FAPI PET in Pleural Mesothelioma: the Diagnostic Accuracy and Clinical Value of FAPI PET At Diagnosis, Primary Staging, and the Feasibility of FAPI PET for Response Evaluation

Study Details

Description:

The FAPI PET/CT results will be compared to conventional imaging (including FDG PET/CT). The diagnostic accuracy will be determined with histopathology as reference standard.

Sponsor:

Aalborg University Hospital

Contacts:

Morten Bentestuen, MD

m.bentestuen@rn.dk

+45 97665500

Government Study Link:

NCT06790082 - Click here to see study on

ClinicalTrials.gov

Drug Details

[68Ga]Ga-FAPI-46
Isotope(s):
    GALLIUM-68
    Radioisotope: Ga-68
    Theranostic Role: PET Imaging
    T1/2 (Half-Life): 68 minutes
    Decay Mode: POSITRON β+ (88.9%), GAMMA, ELECTRON CAPTURE (8.7%)
    Energy: Beta: max 1.9 MeV Gamma 1.1 MeV, 511 keV
    Range: N/A
    Decay Daughters: Zn68 (Stable)
    Status: FDA Approvals: NETSPOT® (2016), LOCAMETZ® (2022), ILLUCIX® (2021)
  • GALLIUM-68
Target(s):
  • FAP

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468